Home Information for Clinicians Study Site Locations

Interested in Referring a Patient?

If you have a patient you are interested in referring, please contact us.

A representative of Myrexis, Inc. will call you to discuss the trials currently enrolling patients and whether this could be a good fit for your patient.

Trial Site Locations PDF Print
This "Information for Clinicians" section of the Azixa™ (verubulin, MPC‑6827) GBM Clinical Trials website is intended primarily for the use of healthcare professionals.


For location and contact information, click the following links to be directed to the clinicaltrials.gov page for additional information.

Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme (NCT01285414)

MPC-6827 for Recurrent Glioblastoma Multiforme (NCT00892931)